Statistics

Total Visits

Views
Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy71

Select a period of time:

Number of views in the range

Views
Phase II multicenter study to analyze the predictive value of fusion gene TMPRSS2-ETS assessed both in tumor and blood sample, as a marker of response to enzalutamide in patients with metastatic castration resistant prostate cancer (CRPC) pre-chemotherapy43

Views

Views
May 20251
June 20251
July 202522
August 20259
September 20256
October 20253
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil19
United States9
United Kingdom5
Venezuela2
Canada1
Ecuador1
France1
Hungary1
Italy1
Kenya1
 

Top cities views

Views
Belo Horizonte1
Canoas1
Caracas1
Chapecó1
Clermont-Ferrand1
Crestline1
Cristalina1
Curitiba1
Dallas1
Embu das Artes1